HB 1006 – Maryland
Introduced: 2022 Status: Inactive / Dead
Requiring a pharmacy benefits manager or purchaser to maintain a reasonably adequate and accessible network of pharmacies; prohibiting a pharmacy benefits manager or purchaser from requiring a pharmacy or pharmacist to obtain or maintain certain …
HB 1007 – Maryland
Introduced: 2022 Status: Inactive / Dead
Altering the reimbursement levels for drug products that the Maryland Medical Assistance Program is required to establish and that pharmacy benefits managers that contract with a pharmacy on behalf of a managed care organization are …
HB 1008 – Maryland
Introduced: 2022 Status: Inactive / Dead
Prohibiting a pharmacy benefits manager or purchaser from prohibiting a beneficiary from selecting a pharmacy or pharmacist of the beneficiary’s choosing, denying a pharmacy or pharmacist the right to participate in a network, imposing certain …
HB 1009 – Maryland
Introduced: 2022 Status: Inactive / Dead
Altering the application of the prohibition on pharmacy benefits managers reimbursing a pharmacy or pharmacist in an amount less than the pharmacy benefits manager reimburses itself or an affiliate; repealing provisions of law relating to …
HB 1009 (see companion bill SB 700) – Maryland
Introduced: 2019 Status: Inactive / Dead
Repealing the initial cap on participation in a certain waiver; requiring a certain waiver submitted by the Maryland Department of Health to the Centers for Medicare and Medicaid Services to include a request for a …
HB 1014 (see companion bill SB 690) – Maryland
Introduced: 2022 Status: Inactive / Dead
Pharmacy Benefits Managers – Definitions of Carrier, ERISA, and Purchaser. Repealing the definitions of “carrier” and “ERISA” and altering the definition of “purchaser” for the purpose of applying certain provisions of State insurance law governing …
HB 1015 – Maryland
Introduced: 2022 Status: Inactive / Dead
Repealing the authority of certain pharmacy benefits managers to require a beneficiary to use a specific pharmacy or entity for a specialty drug; and altering the application of the prohibition on certain pharmacy benefits managers …
HB 1034 – Maryland
Introduced: 2021 Status: Enacted
Repealing the date by which the Prescription Drug Affordability Board is required to submit a certain plan of action regarding the establishment of a process for setting the upper payment limits for certain prescription drug …
HB 1035 (see companion bill SB 728) – Maryland
Introduced: 2022 Status: Inactive / Dead
Altering the purpose of the Maryland Health Benefit Exchange Fund to include the provision of funding for the establishment and operation of the Qualified Resident State Subsidy Program; requiring the Maryland Health Benefit Exchange to …
HB 1042 (see companion bill SB 884) – Maryland
Introduced: 2020 Status: Inactive / Dead
State Prescription Drug Benefits – Retiree Benefits – Revisions. Altering the date on which the State shall discontinue certain prescription drug benefits to certain persons if a certain event occurs; altering the date by which …
HB 1059 – Maryland
Introduced: 2019 Status: Inactive / Dead
Requiring the Maryland Health Care Commission to publish a certain notice of the closing or partial closing of a certain health care facility within a certain time period; requiring the Commission to ensure that a …
HB 1087 (see companion bill SB 871) – Maryland
Introduced: 2019 Status: Inactive / Dead
Providing that the General Assembly finds that all State residents have a right to health care; providing it is the intent of the General Assembly to establish a comprehensive universal single-payer health care coverage program …
HB 1098 – Maryland
Introduced: 2019 Status: Enacted
Health Insurance – Maryland Health Benefit Exchange – Small Business Tax Credit Subsidy: Altering the contents of the Maryland Health Benefit Exchange Fund; authorizing the Maryland Health Benefit Exchange, in consultation with the Maryland Insurance …
HB 1100 – Maryland
Introduced: 2020 Status: Enacted
Requiring the Prescription Drug Affordability Board to meet four times per year instead of every 6 weeks; repealing the requirement that the Board hire general counsel; providing that the Attorney General is the legal advisor …
HB 1108 – Maryland
Introduced: 2023 Status: Inactive / Dead
Altering the process by which health insurance carriers and managed care organizations determine participation by providers on provider panels; and requiring internal review systems to include grievances involving the rejection of a provider’s application to …
HB 1119 – Maryland
Introduced: 2020 Status: Inactive / Dead
Pharmacists – Required Notification and Authorized Substitution – Lower–Cost Drug or Device Product. Requiring a pharmacist, or the pharmacist’s designee who is under certain supervision, to inform a certain consumer of the availability of certain …